Power Law company profile

Viela Bio

Biotech & Life Sciences · Gaithersburg, United States · Founded 2018 · IPO 2019 Unicorn

Clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases

Valuation

$3.05B

Market cap · 2026

Revenue

$12M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

9 investors on Viela Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Boyu Capital

Sirona Capital

6 Dimensions Capital

Hillhouse Capital

Temasek

Series B+ 4 investors entered at this stage

Cormorant Asset Management

Goldman Sachs

HBM Healthcare Investments

Viking Global Investors

Global footprint

Where Viela Bio has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States84.1%

🇮🇳 India15.9%

2 countries shown

Patent intelligence

$43M patent portfolio · 34 active families

Estimated portfolio value

$43M

1.4% of market cap · 47.5× smaller than top peer Ablynx ($2B)

34 active patent families

Where Viela Bio innovates Molecular biologyAutoimmune diseaseAutoimmune conditionBiochemistryPharmacology

Where Viela Bio concentrates vs peers

Each axis is a top-10 topic across Viela Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Viela Bio

An AI-synthesized read of the highest-engagement posts about Viela Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Viela Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles